VRTX

NASDAQ 已收盘

Vertex Pharmaceuticals

536.45 USD
▲+2.25+0.42%
盘后 539.00 +0.48%
2026-11-18
市值
$132.01B
市盈率
33.48
EPS
15.55
股息率
—
52 周区间
412.27 – 568.67
成交量
1.29M
Beta
0.28
目标价
595.36
52W 低 412.2752W 高 568.67
价格走势

公司简介

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMK...

关联新闻